S&P 500   4,585.59
DOW   36,117.38
QQQ   390.43
Forward dividend yield: What it is and how to use it 
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
What are consumer staples stocks?
Healthcare sector: Overview and keys to investing
All the trading advice you’ve ever received boils down to this (Ad)
Is Amazon a blue chip stock?
How to find penny stocks to invest and trade 
All the trading advice you’ve ever received boils down to this (Ad)
How to invest in GTE technology: A guide 
Consumer staples vs. consumer discretionary
S&P 500   4,585.59
DOW   36,117.38
QQQ   390.43
Forward dividend yield: What it is and how to use it 
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
What are consumer staples stocks?
Healthcare sector: Overview and keys to investing
All the trading advice you’ve ever received boils down to this (Ad)
Is Amazon a blue chip stock?
How to find penny stocks to invest and trade 
All the trading advice you’ve ever received boils down to this (Ad)
How to invest in GTE technology: A guide 
Consumer staples vs. consumer discretionary
S&P 500   4,585.59
DOW   36,117.38
QQQ   390.43
Forward dividend yield: What it is and how to use it 
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
What are consumer staples stocks?
Healthcare sector: Overview and keys to investing
All the trading advice you’ve ever received boils down to this (Ad)
Is Amazon a blue chip stock?
How to find penny stocks to invest and trade 
All the trading advice you’ve ever received boils down to this (Ad)
How to invest in GTE technology: A guide 
Consumer staples vs. consumer discretionary
S&P 500   4,585.59
DOW   36,117.38
QQQ   390.43
Forward dividend yield: What it is and how to use it 
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
What are consumer staples stocks?
Healthcare sector: Overview and keys to investing
All the trading advice you’ve ever received boils down to this (Ad)
Is Amazon a blue chip stock?
How to find penny stocks to invest and trade 
All the trading advice you’ve ever received boils down to this (Ad)
How to invest in GTE technology: A guide 
Consumer staples vs. consumer discretionary

Reneo Pharmaceuticals (RPHM) Stock Forecast & Price Target

$7.00
-0.03 (-0.43%)
(As of 12/7/2023 ET)
Compare
Today's Range
$6.93
$7.36
50-Day Range
$5.90
$8.43
52-Week Range
$1.79
$11.30
Volume
664,294 shs
Average Volume
138,491 shs
Market Capitalization
$233.18 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$32.78

Reneo Pharmaceuticals Consensus Analyst Rating and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

Buy
Based on 3 Analyst Ratings

Analysts' Consensus Price Target

$32.78
368.21% Upside
High Forecast$35.55
Average Forecast$32.78
Low Forecast$30.00
TypeCurrent Forecast
12/8/22 to 12/8/23
1 Month Ago
11/8/22 to 11/8/23
3 Months Ago
9/9/22 to 9/9/23
1 Year Ago
12/8/21 to 12/8/22
Consensus Rating
Buy
Buy
Buy
Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
3 Buy rating(s)
2 Buy rating(s)
2 Buy rating(s)
4 Buy rating(s)
Hold
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$32.78$30.00$30.00$24.75
Predicted Upside368.21% Upside265.41% Upside308.72% Upside454.76% Upside
Get Reneo Pharmaceuticals Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for RPHM and its competitors with MarketBeat's FREE daily newsletter.


RPHM Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

RPHM Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Reneo Pharmaceuticals Stock vs. The Competition

TypeReneo PharmaceuticalsMedical CompaniesS&P 500
Consensus Rating Score
3.00
2.68
2.49
Consensus RatingBuyModerate BuyHold
Predicted Upside368.21% Upside658.24% Upside1,909.52% Upside
News Sentiment RatingNeutral News
Positive News
Positive News

Recent Analyst Ratings and Stock Forecasts

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
11/15/2023William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$35.55+460.72%
11/14/2023HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
M. Kapoor
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$30.00+380.00%
7/3/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 05:06 AM ET.












RPHM Price Target - Frequently Asked Questions

What is Reneo Pharmaceuticals's consensus rating and price target?

According to the issued ratings of 3 analysts in the last year, the consensus rating for Reneo Pharmaceuticals stock is Buy based on the current 3 buy ratings for RPHM. The average twelve-month price prediction for Reneo Pharmaceuticals is $32.78 with a high price target of $35.55 and a low price target of $30.00. Learn more on RPHM's analyst rating history.

Do Wall Street analysts like Reneo Pharmaceuticals more than its competitors?

Analysts like Reneo Pharmaceuticals more than other Medical companies. The consensus rating for Reneo Pharmaceuticals is Buy while the average consensus rating for medical companies is Moderate Buy. Learn more on how RPHM compares to other companies.

Does Reneo Pharmaceuticals's stock price have much upside?

According to analysts, Reneo Pharmaceuticals's stock has a predicted upside of 420.65% based on their 12-month stock forecasts.

What analysts cover Reneo Pharmaceuticals?

Reneo Pharmaceuticals has been rated by HC Wainwright, and William Blair in the past 90 days.


Stock Ratings Reports and Tools

This page (NASDAQ:RPHM) was last updated on 12/8/2023 by MarketBeat.com Staff

My Account -